DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) announced a quarterly dividend on Wednesday, July 31st, Zacks reports. Shareholders of record on Friday, September 27th will be given a dividend of 0.16 per share by the medical instruments supplier on Friday, October 11th. This represents a $0.64 dividend on an annualized basis and a yield of 2.36%. The ex-dividend date is Friday, September 27th.
DENTSPLY SIRONA has increased its dividend payment by an average of 11.9% annually over the last three years and has increased its dividend every year for the last 13 years. DENTSPLY SIRONA has a payout ratio of 27.1% meaning its dividend is sufficiently covered by earnings. Research analysts expect DENTSPLY SIRONA to earn $2.32 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 27.6%.
DENTSPLY SIRONA Price Performance
XRAY stock opened at $27.14 on Thursday. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a one year low of $23.94 and a one year high of $41.56. The firm has a market capitalization of $5.64 billion, a PE ratio of -61.68, a P/E/G ratio of 1.20 and a beta of 1.01. The firm has a 50-day moving average of $26.24 and a two-hundred day moving average of $30.18.
Insider Buying and Selling at DENTSPLY SIRONA
In related news, Director Gregory T. Lucier purchased 3,577 shares of the stock in a transaction on Friday, May 31st. The shares were bought at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the acquisition, the director now directly owns 58,374 shares in the company, valued at approximately $1,631,553.30. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.52% of the company’s stock.
Analyst Ratings Changes
A number of analysts have recently issued reports on the stock. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. Evercore ISI reduced their price target on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th. The Goldman Sachs Group reduced their price target on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a research report on Monday, May 6th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of DENTSPLY SIRONA in a research report on Monday, July 8th. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $33.44.
Check Out Our Latest Research Report on DENTSPLY SIRONA
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
See Also
- Five stocks we like better than DENTSPLY SIRONA
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Meta Platforms: Rotation or Not, It’s Rally On For This AI Stock
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Humana Slides on Profitability Concerns Despite Q2 Earnings Beat
- Best Stocks Under $10.00
- Procter & Gamble Stock Drops Despite Earnings Beat – What to Know
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.